Seeking Alpha
View as an RSS Feed

Life Sciences Report  

Latest comments  |  Highest rated
  • Advocacy And Technology Move Stem Cell Research Forward: Bernie Siegel Of The Genetics Policy Institute [View article]
    You are right. The stem cell business does have huge potential.
    You can read this article in its entirety here:
    Oct 12, 2015. 12:43 PM | Likes Like |Link to Comment
  • Fallen Biotech Angels To Arise: John McCamant And Jay Silverman Of The Medical Technology Stock Letter [View article]
    Thank you!
    Oct 2, 2015. 01:41 PM | Likes Like |Link to Comment
  • The Big Picture: Edison's Pooya Hemami Looks Beyond Cancer For Biotech Winners [View article]
    Great info! Thanks docsbp.
    Jul 1, 2015. 02:53 PM | Likes Like |Link to Comment
  • Why Investors Shouldn't Worry About Explosive New Drug Pricing: Maxim's Jason Kolbert [View article]
    Many of our experts have pointed out that while the majority of companies do not succeed, the ones that do are so successful they more than make up for those losses. And in this article ( ) Roth Capital Partners Analyst Joseph Pantginis talked about companies that bounce back from bad data. “After bad data, it goes back to what can be gleaned from the data that might be positive. Is there something a company can use to claw back into the good graces of investors—some positive data that might not have been so obvious at first? Are there other indications being developed for the drug? A company might say, "OK, this drug didn't work in this indication, so we are going to try something else." He pointed to successes at Genentech and Amgen as examples.
    Jul 1, 2015. 02:39 PM | Likes Like |Link to Comment
  • As Cancer Immunotherapy Turns 125, WBB Securities' Steve Brozak Ponders What Investors Can Expect From Biotech Next [View article]
    Cancer immunotherapy investments are a hot topic that have been crossing our radar a lot lately. Read what Analyst George Zavoico told us in our latest interview, "Opportunities in Cancer Immunotherapy Throttle Up"
    Jun 29, 2015. 04:20 PM | Likes Like |Link to Comment
  • Bloom Burton's David Martin Zeroes In On Under-The-Radar Biotech [View article]
    Here are a couple:
    Feb 19, 2015. 04:52 PM | Likes Like |Link to Comment
  • 3 Biotech Investment Ideas That Disrupt And Diversify: Anita Dushyanth [View article]
    @Lost0kie51 - The company is: Theralase Technologies Inc.
    Sep 29, 2014. 05:36 PM | Likes Like |Link to Comment
  • Biotechs With Upside Target Ebola And Liver Disease: MLV's Vernon Bernardino [View article]
    Interview can be read in full here:
    Sep 11, 2014. 05:51 PM | Likes Like |Link to Comment
  • Steve Brozak: Big-Picture Biotech Stocks Rule The Future [View article]
    Interview can be read in full, here:
    Sep 9, 2014. 07:40 PM | Likes Like |Link to Comment
  • Innovative Australian Companies On Canaccord Analyst Matthijs Smith's Opportunity List [View article]
    Full interview can be read here:
    Aug 28, 2014. 04:14 PM | Likes Like |Link to Comment
  • Wedbush Securities' Liana Moussatos On The Art And Science Of Picking Biotechs With Upside [View article]
    Full article available here:
    Aug 22, 2014. 04:38 PM | Likes Like |Link to Comment
  • Medtech Shifts From High Gear Into Overdrive: Canaccord's William Plovanic [View article]
    The full article is available for free here:
    Aug 20, 2014. 02:43 PM | Likes Like |Link to Comment
  • Taking Stock Of The New Normal: Mark Landy On New Growth Ideas For Biotech Investors [View article]
    Full article available here:
    Aug 8, 2014. 02:20 PM | Likes Like |Link to Comment
  • Christopher James Turns A Clinical Eye On Biotechs With High Reward Potential [View article]
    Full article available here:
    Aug 4, 2014. 02:05 PM | Likes Like |Link to Comment
  • ROTH Capital's Debjit Chattopadhyay: Marriage Of Diagnostics To New Therapies Breeds Biotech Winners [View article]
    Full article can be read here:
    Jul 25, 2014. 02:36 PM | Likes Like |Link to Comment